Outcomes of Cutaneous Surgery for Nonmelanoma Skin Cancer in Patients with Different Fitzpatrick Skin Types: A Nationwide, Multicenter, Prospective Study

By sjmartinez • February 1, 2024

Nadir U, Yi MD, Koza E, Shi VJ, Dave L, Hisham FI, Maisel-Campbell A, Lin KA, Ibrahim SA, Kang BY, Anvery N, Dirr MA, Christensen RE, Riley JM, Kundu RV, Aylward JL, Bari O, Bhatti H, Bolotin D, Cherpelis BS, Cohen JL, Condon S, Farhang S, Firoz B, Garrett AB, Geronemus RG, Golda NJ, Humphreys TR, Hurst EA, Jacobson OH, Jiang SB, Karia PS, Kimyai-Asadi A, Kouba DJ, Council ML, Le M, MacFarlane DF, Maher IA, Miller SJ, Moioli EK, Morrow M, Neckman J, Peterson SR, Poblete-Lopez C, Prather CL, Ranario JS, Rubin AG, Swanson AM, Urban C, Xu YG, Pearlman R, Cahn BA; Dermbase Research Group; Yoo S, Harikumar V, Weil A, Schaeffer M, Iyengar S, Poon E, Alam M. Outcomes of Cutaneous Surgery for Nonmelanoma Skin Cancer in Patients with Different Fitzpatrick Skin Types: A Nationwide, Multicenter, Prospective Study. J Am Acad Dermatol. 2024 Jan 29:S0190-9622(24)00137-3. doi: 10.1016/j.jaad.2023.11.069. Epub ahead of print. PMID: 38296200.

Tags: Cancer, cutaneous, Dermatology, Fitzpatrick, multicenter, nonmelanoma, Outcomes, patients, prospective, Publications, Resident, skin, skin of color, study, Surgery, type

International development of Investigator Global Assessment scores for pemphigus

Murrell DF, Boucher D, Daneshpazhooh M, Mahmoudi H, Kianfar N, Dasdar S, Yale M, Wilson A, Bilgic A, Uzun S, Chandran NS, Patsatsi A, Drenovska[...]

Envudeucitinib, a Potent, Next-Generation, Allosteric Inhibitor of TYK2: A Narrative Review

Armstrong AW, Krueger JG, Strober BE, Stein Gold LF, Desai SR, Muscianisi E, Klyachkin Y, Ucpinar S, Tilley MK, Blauvelt A. Envudeucitinib, a Potent, Next-Generation,[...]

Incubating Artificial Intelligence (AI) Initiatives and Careers in Dermatology

Wongvibulsin S, Primiero CA, Adamson AS, Barata C, Betz-Stablein B, Celebi ME, Dawant B, Guitera P, Kelly KM, Kittler H, Kose K, Landman B, Lehman[...]